CNR1 and osteoarthritis: For example, FABP5 inhibition or knockdown produces CB1‐dependent analgesia in inflammatory pain, osteoarthritis and chronic constriction injury (Berger et al., 2012; Bogdan et al., 2018, 2022; Fauzan et al., 2022; Gordon et al., 2024; Kaczocha et al., 2014, 2015; Peng et al., 2017; Yan et al., 2018; Zhu et al., 2023).